Back to search

Japan· JP-2189019M1047

オメガ-3脂肪酸エチル

A medicinal product containing オメガ-3脂肪酸エチル, registered in Japan by 陽進堂ホールディングス, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedオメガ-3脂肪酸エチルATC—REGISTER NO.JP-2189019M1047PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
オメガ-3脂肪酸エチル
Manufacturer
陽進堂ホールディングス
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

オメガ-3脂肪酸エチル in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All オメガ-3脂肪酸エチル products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Omacor, Zodin
  • Belgium · Omacor
  • Bulgaria · Омакор
  • Cyprus · Omacor
  • Germany · Omacor, Zodin
  • Denmark · Lipomeg
  • Estonia · Omacor
  • Spain · Ácidos Omega-3 Strides, Omacor
  • France · Esters Ethyliques D’acides Omega 3 Eg Labo Conseil, Esters Ethyliques D’acides Omega-3 Ibsa
  • United Kingdom (Northern Ireland) · Omacor, Omega 3-Acid-Ethyl Esters Strides Pharma Uk
  • Greece · Becolip, Lipemia Forte
  • Croatia · Dualtis, Omacor
  • Hungary · Omacor
  • Ireland · Omacor, Trimega
  • Italy · Agemo, Eskim
  • Lithuania · Omacor
  • Luxembourg · Omacor
  • Latvia · Omacor
  • Malta · Omacor
  • Netherlands · Omacor
  • Norway · Omacor
  • Poland · Omacor
  • Portugal · Ésteres Etílicos 90 Dos Ácidos Ómega-3 Pharmanel, Omacor
  • Romania · Omacor
  • Sweden · Lipomeg
  • Slovenia · Omacor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/658d7257-59f7-47a5-b3f6-2bab98ffdfe0
GET /v1/drugs/658d7257-59f7-47a5-b3f6-2bab98ffdfe0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "2g1包",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2189019M1047",
  "category": "内用薬",
  "price_yen": 72.3,
  "generic_name": "オメガ-3脂肪酸エチル",
  "product_name_jp": null,
  "therapeutic_class": "2189",
  "transitional_expiry": null
}

See everything about オメガ-3脂肪酸エチル.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.